Literature DB >> 36175668

Prognostic significance of chromosome arm 1q gain and methylation class in molecularly defined diffuse leptomeningeal glioneuronal tumor.

Jason Chiang1, Daniel C Moreira2,3, Xiaoyu Li4, Larissa V Furtado4.   

Abstract

Entities:  

Year:  2022        PMID： 36175668     DOI： 10.1007/s00401-022-02507-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   15.887


× No keyword cloud information.
  3 in total

1.  Chromosome arm 1q gain is an adverse prognostic factor in localized and diffuse leptomeningeal glioneuronal tumors with BRAF gene fusion and 1p deletion.

Authors:  Jason Chiang; James Dalton; Santhosh A Upadhyaya; Zoltán Patay; Ibrahim Qaddoumi; Xiaoyu Li; Annette D Segura; Suash Sharma; Azzam Ismail; Sheila A Shurtleff; Susana C Raimondi
Journal:  Acta Neuropathol       Date:  2018-11-21       Impact factor: 17.088

2.  Low-grade spinal glioneuronal tumors with BRAF gene fusion and 1p deletion but without leptomeningeal dissemination.

Authors:  Jason C H Chiang; Julie H Harreld; Brent A Orr; Suash Sharma; Azzam Ismail; Annette D Segura; David W Ellison
Journal:  Acta Neuropathol       Date:  2017-05-25       Impact factor: 17.088

3.  Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.

Authors:  Maximilian Y Deng; Martin Sill; Jason Chiang; Jens Schittenhelm; Martin Ebinger; Martin U Schuhmann; Camelia-Maria Monoranu; Till Milde; Andrea Wittmann; Christian Hartmann; Clemens Sommer; Werner Paulus; Jutta Gärtner; Wolfgang Brück; Thomas Rüdiger; Alfred Leipold; Zane Jaunmuktane; Sebastian Brandner; Felice Giangaspero; Paolo Nozza; Jaume Mora; Andres Morales la Madrid; Ofelia Cruz Martinez; Jordan R Hansford; Torsten Pietsch; Anna Tietze; Pablo Hernáiz-Driever; Iris Stoler; David Capper; Andrey Korshunov; David W Ellison; Andreas von Deimling; Stefan M Pfister; Felix Sahm; David T W Jones
Journal:  Acta Neuropathol       Date:  2018-05-15       Impact factor: 17.088
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.